Repare Therapeutics Inc.
NASDAQ:RPTX
3.58 (USD) • At close November 1, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Omzet
| 51.133 | 131.83 | 7.6 | 0.135 | 0 | 0 | 0 |
Kosten van de omzet
| 1.951 | 4.184 | 3.344 | 1.787 | 0.968 | 0.407 | 0.102 |
Brutowinst
| 49.182 | 127.646 | 4.256 | -1.652 | -0.968 | -0.407 | -0.102 |
Brutowinstmarge
| 0.962 | 0.968 | 0.56 | -12.237 | 0 | 0 | 0 |
Onderzoek- en ontwikkelingskosten
| 130.294 | 119.066 | 90.047 | 40.091 | 20.995 | 9.906 | 4.401 |
Algemene en administratieve kosten
| 33.764 | 32.56 | 26.213 | 14.346 | 5.382 | 2.914 | 1.774 |
Verkoop- en marketingkosten
| -0.116 | 0 | 0 | 0 | 0 | 0 | 0 |
Verkoop-, algemene en administratieve kosten
| 33.648 | 32.56 | 26.213 | 14.346 | 5.382 | 2.914 | 1.774 |
Overige kosten
| -0.119 | -0.043 | -0.041 | -0.016 | -1.356 | -1.136 | -1.474 |
Bedrijfskosten
| 163.942 | 151.626 | 116.26 | 54.437 | 26.377 | 12.82 | 6.175 |
Bedrijfsresultaat
| -114.76 | -19.796 | -108.66 | -54.302 | -26.377 | -12.82 | -6.175 |
Bedrijfsresultaat ratio
| -2.244 | -0.15 | -14.297 | -402.237 | 0 | 0 | 0 |
Totaal overige inkomsten en kosten netto
| 13.045 | 5.896 | 0.074 | -0.44 | -0.644 | -1.428 | -1.621 |
Inkomen voor belasting
| -101.715 | -13.9 | -108.586 | -54.742 | -27.021 | -14.248 | -7.796 |
Inkomen voor belasting ratio
| -1.989 | -0.105 | -14.288 | -405.496 | 0 | 0 | 0 |
Belastingkosten
| -7.919 | 15.147 | -1.678 | -1.325 | 0.195 | 0.035 | 0.147 |
Nettowinst
| -93.796 | -29.047 | -106.908 | -53.417 | -27.216 | -14.283 | -7.796 |
Nettowinstmarge
| -1.834 | -0.22 | -14.067 | -395.681 | 0 | 0 | 0 |
WPA (Winst Per Aandeel)
| -2.23 | -0.69 | -2.83 | -1.45 | -0.74 | -0.9 | -0.49 |
Verwaterde WPA
| -2.23 | -0.69 | -2.83 | -1.45 | -0.74 | -0.9 | -0.49 |
EBITDA
| -112.809 | -20.104 | -108.516 | -53.638 | -26.484 | -12.121 | -5.926 |
EBITDA ratio
| -2.206 | -0.152 | -14.278 | -397.319 | 0 | 0 | 0 |